A Dividend Fund's Earnings Marathon Nears Its Finish — With Two Heavyweights Left to Run

VanEck Developed Markets Dividend Leaders ETF sits 0.79% below 52-week high; key earnings from HSBC, Novo Nordisk, and Allianz could trigger a breakout or pullback.

The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF closed Friday at €55.06, a 0.42% dip on the day, leaving it just 0.79% shy of its 52-week high of €55.50. What makes that proximity notable isn't just the momentum — the fund has climbed 6.27% over the past month — but what's coming down the pipeline. Two of its largest holdings report earnings within the next week, and the outcome could determine whether this fund finally breaks through or stalls.

The Financial Sector Now Calls the Shots

The fund's center of gravity has shifted dramatically. During the June rebalancing, financials were boosted to roughly 44% of the portfolio — a deliberate hunt for higher yields in the banking sector. That repositioning means HSBC, now a top holding at over 4.5% weight, carries outsized influence. The bank reports on August 4, the same day as Pfizer, and those numbers will likely set the tone for the week.

Two days later, on August 6, Novo Nordisk delivers its first-half results. The Danish pharma giant sits among the fund's ten largest positions. Then on August 7, Allianz follows with its second-quarter report, coming off a record operating profit in Q1 and running an active share buyback program. For a fund where financials and healthcare dominate, these are the events that move the needle — far more than general market sentiment.

A Strong Start to the Earnings Season

The fund has already received some welcome support. French utility Engie posted a 13.7% rise in net profit to €3.323 billion on Friday, lifting its full-year guidance for adjusted net income to between €4.9 billion and €5.5 billion. Operating profit, excluding the nuclear division, climbed 3.3% to €5.3 billion. Utility stocks with high dividend yields tend to act as ballast in choppy markets, so this was a stabilizing print.

The energy sector also delivered. Chevron reported a record second-quarter profit of $12.1 billion, with adjusted earnings per share of $6.06 beating the $5.56 analyst consensus. But here's the twist: energy carries far less weight in the fund than it once did. The June rebalancing slashed the sector's allocation from roughly 19% to about 11.5%. The reason was mechanical — the spring oil rally pushed energy share prices so high that their dividend yields fell below the fund's inclusion threshold. Chevron's blockbuster quarter still supports the net asset value, just with considerably less leverage than in the first half.

A Technical Picture Nearing Its Limits

The fund's 14-day RSI sits at 68.2, brushing against the 70 threshold that traders typically read as overbought. With a year-to-date gain of 14.61% and a 12-month advance of 27.79%, the rally has been substantial. The proximity to the 52-week high signals an intact uptrend, but it also leaves the fund vulnerable to a pullback if the upcoming earnings disappoint.

The fund holds 112 positions, with the top ten — including Verizon, Nestlé, Shell, TotalEnergies, PepsiCo, and Intesa Sanpaolo alongside Novo Nordisk and Allianz — accounting for 34.83% of assets. That diversification tempers single-stock risk, though the sector concentration in financials, energy, and healthcare means sector-specific news still punches above its weight. The underlying index only rebalances twice a year, in June and December, so the current allocation will persist regardless of near-term market moves.

Income Investors Watch the Calendar

For yield-focused shareholders, the distribution schedule matters as much as price action. The fund's last payout came on June 9, 2026, following distributions in March 2026, December 2025, and September 2025. The next payment is expected in September 2026, maintaining the quarterly rhythm.

With roughly €8.9 billion in assets under management, the fund trades under the ticker TDIV and anchors VanEck's dividend lineup. A smaller ex-US variant holds just $15.6 million in AUM. Both track Morningstar dividend indices passively, though their geographic focus differs — a distinction that shapes currency and sector exposure.

The coming week will test whether this fund can convert technical strength into a new record. Solid numbers from Novo Nordisk and Allianz could push the ETF past €55.50 within days. Disappointments, given the elevated RSI, could just as quickly trigger a consolidation. Either way, the earnings gauntlet that began with Engie and Chevron now rests on the shoulders of a Danish pharma giant and a German insurer.